HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series.

Abstract
Our group and others internationally have previously reported data on the use of low-dose flumazenil administered intravenously for the management of benzodiazepine withdrawal. This paper describes the first reported use of subcutaneous flumazenil infusion in the management of acute benzodiazepine withdrawal. Self-reported withdrawal symptoms and psychological state and anxiety sequelae were collected at baseline and then at intervals to 5 days following initiation of subcutaneous flumazenil infusion. Data indicate that patient subjective benzodiazepine withdrawal symptoms were well managed, with significant reduction in psychological distress seen over the duration of treatment. Perceived difficulty in performing everyday functions was positively correlated with withdrawal severity and improved over treatment. Patients reported high treatment comfort, willingness to undertake a future subsequent treatment using this technique, and willingness to recommend this treatment to a friend. This small proof-of-concept study indicates that subcutaneous flumazenil infusion has excellent tolerability, efficacy and improvement on measures of psychological distress. Given this technique is less invasive and requires fewer staff resources compared with intravenous administration, it may prove a significant asset in the management of benzodiazepine withdrawal.
AuthorsGary Hulse, George O'Neil, Noella Morris, Kellie Bennett, Amanda Norman, Sean Hood
JournalJournal of psychopharmacology (Oxford, England) (J Psychopharmacol) Vol. 27 Issue 2 Pg. 222-7 (Feb 2013) ISSN: 1461-7285 [Electronic] United States
PMID22596209 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Benzodiazepines
  • Flumazenil
Topics
  • Adult
  • Aged
  • Anxiety Disorders (etiology, psychology)
  • Benzodiazepines (adverse effects)
  • Female
  • Flumazenil (therapeutic use)
  • Humans
  • Infusions, Subcutaneous
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Substance Withdrawal Syndrome (drug therapy, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: